Course: Clinical Approach to Vitiligo and Emerging Therapies
Clinical Approach to Vitiligo and Emerging Therapies
Raja Sivamani, MD MS AP
Supported by an independent educational grant from Incyte

This session will review the clinical presentation of vitiligo and when to consider the use of systemic agents. The associated autoimmune, physical, and psychological co-morbidities will be reviewed. The clinical evidence for the use of JAK inhibition, such as topical JAK inhibitors, will be discussed.

Learning Objectives:

  1. Discuss the diagnostic approach, differential diagnosis, and physical and psychological co-morbidities of vitiligo
  2. Review the various presentations of vitiligo and when to consider topical vs systemic therapies for pediatric and adult populations
  3. Define and balance the clinical evidence and the risk profile for use of topical and oral JAK/TEC inhibition in vitiligo

Faculty

User: Raja Sivamani
Raja Sivamani
MD MS AP

Dr. Raja Sivamani is a board-certified dermatologist and practices as an integrative dermatologist at Pacific Skin Institute. He is an Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis and Director of Clinical Research and the Clinical Trials Unit.He is also an Adjunct Assistant Professor in the Department of Biological Sciences at the California State University, Sacramento and an Associate Professor of Dermatology at California Northstate University, College of Medicine.He engages in clinical practice as well as both clinical and translational research that integrates bioengineering, nutrition, cosmetics, and skin biology. With training in both Allopathic and Ayurvedic medicine, he takes an integrative approach to his patients and in his research.He has published over 100 peer-reviewed research manuscripts, 10 textbook chapters, and a textbook entitled Cosmeceuticals and Active Cosmetics, 3rd Edition with a passion for expanding the evidence and boundaries of integrative medicine for skin care.

View Bio

Editors

User: Iltefat Hamzavi
Iltefat Hamzavi
MD

Dr. Iltefat Hamzavi is a dermatologist who works at Henry Ford Hospital and Hamzavi/Dermatology Specialists. His work has a focus on vitiligo, photomedicine, and hidradenitis suppurativa. Within vitiligo his work has focused on improving phototherapy options for vitiligo patients. His group has also led North American efforts in developing surgical treatments for vitiligo. He has participated in developing the VASI score and updated scores as a way to measure treatment response for vitiligo patients. He is also one of the founders and Co-chair of the Global Vitiligo Foundation. This is a group which aims to improve the lives of vitiligo patients by supporting initiatives like the World Vitiligo Day and vitiligo research updates. He is a passionate metro Detroiter, husband, and father of 3.

View Bio

Related Courses

All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2024.
This website also contains material copyrighted by 3rd parties.
ABOUT
LEGAL
SUBSCRIBE
To Get Posts Directly In Your Inbox!